Join and Save – AUA Annual Meeting
Become an AUA member and SAVE up to $886 on Annual Meeting registration!
Related Articles
Prostate Enucleation: Contemporary Techniques and Outcomes – American Urological Association
Benign prostatic hyperplasia (BPH) is the most common urological condition, often associated with lower urinary tract symptoms impacting quality of life. It is estimated to…
MACE Risks Before and During Dialysis Initiation May Be Lower With ESA vs HIF-PHI
Anemia is prevalent among patient starting hemodialysis after end-stage kidney disease, and it is tied with major cardiovascular events.
Non–Muscle Invasive-Bladder Cancer Overview
Panelists discuss how non–muscle-invasive bladder cancer (NMIBC) is staged, graded, and treated according to risk stratification, with detailed explanations of low-, intermediate-, and high-risk categories…
Pivotal trial launches of 64Cu-SAR-bisPSMA in BCR of prostate cancer
Results from the phase 3 AMPLIFY trial are intended to support an application to the FDA for potential approval of 64Cu-SAR-bisPSMA.
Editorial Comment | Journal of Urology
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email with instructions to reset your password. Can’t…
Patient selection for cytoreductive nephrectomy in 2025
“Appropriate patient selection for CN is a highly individualized process that is improved with a multidisciplinary approach,” write the authors.
Complication Risks After BPH Surgery Vary by Patients’ CKD Stage, Surgery Type – Renal and Urology News
A study compared postoperative outcomes of laser surgery vs TURP for benign prostatic hyperplasia in patients with various stages of chronic kidney disease.
The Urology News Imaging Competition 2025
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Read our Cookies
Prostate cancer screening: Expert weighs in after Biden’s diagnosis
According to Adam B. Weiner, MD, a urologist at Cedars-Sinai Medical Center, men should begin prostate cancer screening around ages 50 to 55.
Artificial intelligence in bladder cancer diagnostics
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Read our Cookies